Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, Jiangsu province, China.
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 200032, China.
Cancer Lett. 2020 Jul 28;483:114-126. doi: 10.1016/j.canlet.2020.01.037. Epub 2020 Jan 31.
Radioresistance reduces the success of therapy for patients with ESCC. Enhancing our understanding of the cardinal principles of radioresistance may improve the response of patients to irradiation. MicroRNAs perform a key role in posttranscriptional regulation, which is linked with the response of tumors to irradiation. Here, we successfully constructed a radioresistant cell line model, ECA109R, from parental esophageal cancer cell line ECA109. We used RNA-Seq analysis and qRT-PCR to compare the miRNA expression profiles of the ECA109 and ECA109R cell lines. The results revealed that miR-450a-5p was downregulated in the radioresistant cells. Functional analysis indicated that miR-450a-5p increases cellular radiosensitivity and suppresses autophagy in ESCC cells. We utilized a luciferase reporter assay to identify the target gene, DUSP10, as an indispensable regulator of the p38 and SAPK/JNK signaling pathways. Upregulation or downregulation of DUSP10 expression could reverse the effects of miR-450a-5p overexpression or inhibition. Tumor xenograft experiments verified that miR-450a-5p overexpression could increase sensitivity to radiation therapy in vivo. In general, our findings indicate that miR-450a-5p is a latent radiosensitizer and may represent a potential novel therapeutic target for radioresistance in ESCC.
放射抵抗降低了 ESCC 患者治疗的成功率。加深对放射抵抗基本原理的理解可能会提高患者对放疗的反应。miRNA 在转录后调控中发挥关键作用,与肿瘤对放疗的反应有关。在这里,我们成功地从亲本食管癌细胞系 ECA109 构建了放射抵抗细胞系模型 ECA109R。我们使用 RNA-Seq 分析和 qRT-PCR 比较了 ECA109 和 ECA109R 细胞系的 miRNA 表达谱。结果表明,miR-450a-5p 在放射抵抗细胞中下调。功能分析表明,miR-450a-5p 增加了 ESCC 细胞的放射敏感性并抑制了自噬。我们利用荧光素酶报告基因测定鉴定了靶基因 DUSP10,它是 p38 和 SAPK/JNK 信号通路的不可或缺的调节剂。DUSP10 表达的上调或下调可以逆转 miR-450a-5p 过表达或抑制的作用。肿瘤异种移植实验验证了 miR-450a-5p 过表达可以增加体内放射治疗的敏感性。总之,我们的研究结果表明,miR-450a-5p 是一种潜在的放射增敏剂,可能成为 ESCC 放射抵抗的潜在新治疗靶点。